The psychedelic renaissance is underway—but how will it unfold over the next 20 years? Will psychotherapy and mystical experiences remain a crucial element of psychedelic medicine? Will drug companies develop new psychedelics that are superior to classical psychedelics? Or will we invest neuro-hardware that can induce psychedelic experiences without drugs?

Join Zack Lawrence and Ryan Zurrer from Vine Ventures and leading neuroscientists, Robin Carhart Harris and Boris Heifets, from UCSF and Stanford, as they explore the frontier of psychedelic science and industry.